MeritValue

INTELLIGENT BIO SOLUTIONS INC.

INBSdata completeness 88%6 fiscal years on file

Data notes: no data for concept 'interestExpense'; no data for concept 'incomeTaxExpense'

The thesis, from the filings

INTELLIGENT BIO SOLUTIONS INC. earns about -185% on equity, and has bought back 49% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$1.98M1$437,1461$1.26M2$3.11M3$3.05M3
Net income−$7.04M4−$8.31M5−$10.6M6−$10.2M7−$10.6M7
Operating cash flow−$11.3M8−$3.36M9−$7.38M10−$9.57M11−$9.68M11
Capital expenditure———$221,42612$231,83812
Free cash flow (derived)———−$9.79M11−$9.91M11
Total debt—————
Cash & equivalents$12.6M13$8.24M14$1.54M15$6.3M16$1.02M16
Diluted shares10.4M733,26383,7171.6M5.3M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
$5.68
your share of equity
Profit it earned you last year
−$20.04
Free cash flow it threw off
−$18.79
Debt you’d be carrying
—

10 shares is a claim on $5.68 of net worth that earned you −$20.04 and generated −$18.79 of cash last year.

iii. Is this a good business?
Moat signal · return on equity
-185% avg · 5y
FY21 -47%FY22 -125%FY23 -280%FY24 -122%FY25 -353%

It earned an average -185% on equity over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
−49% shares · 5y

Share count is down 49% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 2 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2021-06-30 · accession 0001493152-22-026526 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (RevenueFromContractWithCustomerExcludingAssessedTax)
  4. 10-K · period ending 2021-06-30 · accession 0001493152-22-026526 (NetIncomeLoss)
  5. 10-K · period ending 2022-06-30 · accession 0001493152-23-029992 (NetIncomeLoss)
  6. 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (NetIncomeLoss)
  7. 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (NetIncomeLoss)
  8. 10-K · period ending 2021-06-30 · accession 0001493152-22-026526 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K · period ending 2022-06-30 · accession 0001493152-23-029992 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (NetCashProvidedByUsedInOperatingActivities)
  12. 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (PaymentsToAcquirePropertyPlantAndEquipment)
  13. 10-K · period ending 2021-06-30 · accession 0001493152-22-026526 (CashAndCashEquivalentsAtCarryingValue)
  14. 10-K · period ending 2022-06-30 · accession 0001493152-23-029992 (CashAndCashEquivalentsAtCarryingValue)
  15. 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (CashAndCashEquivalentsAtCarryingValue)
  16. 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (CashAndCashEquivalentsAtCarryingValue)